Piramal Pharma Ltd is confident that the company's American facilities can help it navigate volatility in its largest US market following Donald Trump's return as president, according to chairperson Nandini Piramal.
Trump's second innings as US president is likely to spell uncertainty for pharma companies, she told Mint, referring to his plan to impose import tariffs to make American industry stronger. "I do think there will be an increase in volatility, but one of the benefits is that we do have manufacturing based in the states. For the customers that can pay the prices, we can manufacture for them. Overall, the Indian industry has lower prices for worldwide patients, which is a good thing." Nearly two-thirds of Piramal Pharma's revenue comes from the developed markets, of which the US contributes 35%. The company has three US-based facilities: Riverview, Michighan for making high potency active pharmaceutical ingredients (APIs); Sellersville, Pennsylvania, which manufactures oral solids, creams, liquids and ointments; and Lexington, Kentucky for making sterile injectables.
The company also expects to be better placed in the US in the coming years as the Biosecure Act comes into play.
The US House of Representatives passed the law in September, prohibiting American pharma players from doing business with certain Chinese drug companies starting 2032. Since then, all eyes have been on Indian contract development and manufacturing organizations (CDMOs) such as Piramal Pharma, Syngene, and Neuland Labs as businesses will look to shift their supply chains to an alternative base.
Bu hikaye Mint Mumbai dergisinin November 21, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Mint Mumbai dergisinin November 21, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
World Bank calls for reforming skills training in India
India must make a coordinated effort to reform and rebrand vocational skill training, besides aligning education with the job market, to leverage its demographic advantage to meet the $5-trillion target for its economy, the World Bank said.
FCPA cases take long to conclude after indictment
For investors keen to know the fate of billionaire Gautam Adani's indictment by US authorities, the watchword is patience.
Short-covering, relief rally add ₹7.27 trillion wealth
Markets up 2.39% to hit the highest in six months, a day after Adani's indictment
Wetter monsoon slows pace of adding new transmission lines
India's addition of new power transmission lines fell by half over a year earlier in the April-October period as a wetter-than-usual monsoon slowed work.
COP29's $1.3 tn fund plan disappoints Global South
The 29th edition of the UN climate change conference in Azerbaijan emerged from a deadlock with an annual climate finance goal of $1.3 trillion for developing countries, much to the disappointment of the Global South.
Jaguar rebrand is pink, diverse and doesn't feature any cars
Luxury automaker Jaguar is betting that a colorful and youthful rebrand will help it successfully launch fully into the electric-cars market.
Services up as manufacturing slows in Nov
The HSBC Flash India Services PMI was at 59.2 in Nov from 58.5 in Oct; manufacturing PMI fell slightly from 60.4 to 60.2
MSMED may protect medium firms too
The Centre may consider including medium enterprises for the protection granted under MSME Development (MSMED) Act, 2006, to resolve payment disputes.
Europe boosts Indian textile exports in FY25
Demand for Indian handloom, apparel partly fuelled by Bangladesh crisis
RBI nudges banks to cut speculative bet in rupee
The Indian central bank, in a rare move, instructed some banks to cut their long positions on the dollar-rupee pair on Friday, seeking to curb speculative positions with the currency at a record low, four bankers familiar with the development told Reuters.
